US2019315818A1PendingUtilityA1
Recombinant polypeptides and methods of use thereof
Assignee: IMUNAMI LABORATORIES PTE LTDPriority: Dec 27, 2017Filed: Jun 17, 2019Published: Oct 17, 2019
Est. expiryDec 27, 2037(~11.4 yrs left)· nominal 20-yr term from priority
C07K 14/465A61K 38/00A61P 35/00
70
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present disclosure provides recombinant polypeptides, nucleic acids encoding the recombinant polypeptides and methods for using these polypeptides and/or nucleic acids in enhancing or inducing an immune response in a subject in need thereof. The present disclosure also provides methods of treating a cell proliferative disorder, such as cancer, by administering the disclosed polypeptides and/or nucleic acids to a subject in need thereof.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A nucleic acid encoding a recombinant polypeptide comprising an amino acid sequence having at least 99% sequence identity to the recombinant polypeptide of SEQ ID NO: 9.
2 . An expression vector comprising the nucleic acid of claim 1 .Join the waitlist — get patent alerts
Track US2019315818A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.